1002 related articles for article (PubMed ID: 30774636)
1. Immune Cell Composition in Human Non-small Cell Lung Cancer.
Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Front Immunol; 2018; 9():3101. PubMed ID: 30774636
[TBL] [Abstract][Full Text] [Related]
2. The immune microenvironment in typical carcinoid lung tumour, a brief report of four cases.
Stankovic B; Aamodt H; Bjørhovde HAK; Müller E; Hammarström C; Brustugun OT; Helland Å; Øynebråten I; Corthay A
Scand J Immunol; 2020 Aug; 92(2):e12893. PubMed ID: 32433774
[TBL] [Abstract][Full Text] [Related]
3. Antigen-Presenting Intratumoral B Cells Affect CD4
Bruno TC; Ebner PJ; Moore BL; Squalls OG; Waugh KA; Eruslanov EB; Singhal S; Mitchell JD; Franklin WA; Merrick DT; McCarter MD; Palmer BE; Kern JA; Slansky JE
Cancer Immunol Res; 2017 Oct; 5(10):898-907. PubMed ID: 28848053
[TBL] [Abstract][Full Text] [Related]
4. Determination of poor prognostic immune features of tumour microenvironment in non-smoking patients with lung adenocarcinoma.
Kinoshita T; Kudo-Saito C; Muramatsu R; Fujita T; Saito M; Nagumo H; Sakurai T; Noji S; Takahata E; Yaguchi T; Tsukamoto N; Hayashi Y; Kaseda K; Kamiyama I; Ohtsuka T; Tomizawa K; Shimoji M; Mitsudomi T; Asamura H; Kawakami Y
Eur J Cancer; 2017 Nov; 86():15-27. PubMed ID: 28950145
[TBL] [Abstract][Full Text] [Related]
5. A Protocol for the Comprehensive Flow Cytometric Analysis of Immune Cells in Normal and Inflamed Murine Non-Lymphoid Tissues.
Yu YR; O'Koren EG; Hotten DF; Kan MJ; Kopin D; Nelson ER; Que L; Gunn MD
PLoS One; 2016; 11(3):e0150606. PubMed ID: 26938654
[TBL] [Abstract][Full Text] [Related]
6. APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC.
Li Y; Zhao X; Xiao H; Yang B; Liu J; Rao W; Dai X; Li M; Dai N; Yang Y; Wang D
BMC Cancer; 2021 Mar; 21(1):233. PubMed ID: 33676448
[TBL] [Abstract][Full Text] [Related]
7. The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.
Bremnes RM; Busund LT; Kilvær TL; Andersen S; Richardsen E; Paulsen EE; Hald S; Khanehkenari MR; Cooper WA; Kao SC; Dønnem T
J Thorac Oncol; 2016 Jun; 11(6):789-800. PubMed ID: 26845192
[TBL] [Abstract][Full Text] [Related]
8. Blood immune cell biomarkers in lung cancer.
Riemann D; Cwikowski M; Turzer S; Giese T; Grallert M; Schütte W; Seliger B
Clin Exp Immunol; 2019 Feb; 195(2):179-189. PubMed ID: 30246868
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
[TBL] [Abstract][Full Text] [Related]
10. Contribution of resident and circulating precursors to tumor-infiltrating CD8
Gueguen P; Metoikidou C; Dupic T; Lawand M; Goudot C; Baulande S; Lameiras S; Lantz O; Girard N; Seguin-Givelet A; Lefevre M; Mora T; Walczak AM; Waterfall JJ; Amigorena S
Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33514641
[TBL] [Abstract][Full Text] [Related]
11. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
[TBL] [Abstract][Full Text] [Related]
12. Impaired Tumor-Infiltrating T Cells in Patients with Chronic Obstructive Pulmonary Disease Impact Lung Cancer Response to PD-1 Blockade.
Biton J; Ouakrim H; Dechartres A; Alifano M; Mansuet-Lupo A; Si H; Halpin R; Creasy T; Bantsimba-Malanda C; Arrondeau J; Goldwasser F; Boudou-Rouquette P; Fournel L; Roche N; Burgel PR; Goc J; Devi-Marulkar P; Germain C; Dieu-Nosjean MC; Cremer I; Herbst R; Damotte D
Am J Respir Crit Care Med; 2018 Oct; 198(7):928-940. PubMed ID: 29518341
[TBL] [Abstract][Full Text] [Related]
13. Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer.
Backman M; La Fleur L; Kurppa P; Djureinovic D; Elfving H; Brunnström H; Mattsson JSM; Lindberg A; Pontén V; Eltahir M; Mangsbo S; Gulyas M; Isaksson J; Jirström K; Kärre K; Leandersson K; Mezheyeuski A; Pontén F; Strell C; Lindskog C; Botling J; Micke P
J Pathol; 2021 Nov; 255(3):243-256. PubMed ID: 34339045
[TBL] [Abstract][Full Text] [Related]
14. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
15. CD8
Huang B; Liu R; Wang P; Yuan Z; Yang J; Xiong H; Zhang N; Huang Q; Fu X; Sun W; Li L
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32606053
[TBL] [Abstract][Full Text] [Related]
16. Relationship of dendritic cell density, HMGB1 expression, and tumor-infiltrating lymphocytes in non-small cell lung carcinomas.
Aguilar-Cazares D; Meneses-Flores M; Prado-Garcia H; Islas-Vazquez L; Rojo-Leon V; Romero-Garcia S; Rivera-Rosales RM; Lopez-Gonzalez JS
Appl Immunohistochem Mol Morphol; 2014; 22(2):105-13. PubMed ID: 24752173
[TBL] [Abstract][Full Text] [Related]
17. Chronic Obstructive Pulmonary Disease Alters Immune Cell Composition and Immune Checkpoint Inhibitor Efficacy in Non-Small Cell Lung Cancer.
Mark NM; Kargl J; Busch SE; Yang GHY; Metz HE; Zhang H; Hubbard JJ; Pipavath SNJ; Madtes DK; Houghton AM
Am J Respir Crit Care Med; 2018 Feb; 197(3):325-336. PubMed ID: 28934595
[TBL] [Abstract][Full Text] [Related]
18. CD11c+ and CD123+ dendritic cell subsets in peripheral blood of lung cancer patients.
Afifi SS; Helal AM
Egypt J Immunol; 2009; 16(2):9-15. PubMed ID: 22059349
[TBL] [Abstract][Full Text] [Related]
19. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.
Esendagli G; Bruderek K; Goldmann T; Busche A; Branscheid D; Vollmer E; Brandau S
Lung Cancer; 2008 Jan; 59(1):32-40. PubMed ID: 17825949
[TBL] [Abstract][Full Text] [Related]
20. Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer.
Wang WJ; Tao Z; Gu W; Sun LH
Asian Pac J Cancer Prev; 2013; 14(8):4671-3. PubMed ID: 24083723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
